InsidersTradesSigma
Total declarations
Companies
▲ Purchases (57 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
57
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+18.7%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by COLUMN GROUP L P. Officer active across 2 companies, notably Nurix Therapeutics, Inc.. In total, 62 filings have been logged. Breakdown: 57 buys · 0 sell. Total volume traded: €39.6m. History available since 5 May 2021. The latest transaction was filed on 15 November 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations62 total
949,862 sharesCommon StockSEC:0000950142-24-001000:0
16,791 shares@ US$0.70750.0% of flowCommon StockSEC:0000950170-23-064847:0
Ideal exit: 11 Aug 2024 (T+270)
16,791 shares@ US$0.70750.0% of flowCommon StockSEC:0000950170-23-064858:0
Ideal exit: 11 Aug 2024 (T+270)
16,791 shares@ US$0.70750.0% of flowCommon StockSEC:0000950170-23-064854:0
Ideal exit: 11 Aug 2024 (T+270)
7,542 shares@ US$4.99960.1% of flowCommon StockSEC:0000899243-23-003137:0
Ideal exit: 27 Oct 2023 (T+270)
7,542 shares@ US$4.99960.1% of flowCommon StockSEC:0000899243-23-003130:0
Ideal exit: 27 Oct 2023 (T+270)
7,542 shares@ US$4.99960.1% of flowCommon StockSEC:0000899243-23-003132:0
Ideal exit: 27 Oct 2023 (T+270)
9,900 shares@ US$4.99940.1% of flowCommon StockSEC:0000899243-23-002630:0
Ideal exit: 20 Oct 2023 (T+270)
9,900 shares@ US$4.99940.1% of flowCommon StockSEC:0000899243-23-002642:0
Ideal exit: 20 Oct 2023 (T+270)
9,900 shares@ US$4.99940.1% of flowCommon StockSEC:0000899243-23-002637:0
Ideal exit: 20 Oct 2023 (T+270)
37,639 shares@ US$4.99760.4% of flowCommon StockSEC:0000899243-23-002380:0
Ideal exit: 16 Oct 2023 (T+270)
37,639 shares@ US$4.99760.4% of flowCommon StockSEC:0000899243-23-002375:0
Ideal exit: 16 Oct 2023 (T+270)
37,639 shares@ US$4.99760.4% of flowCommon StockSEC:0000899243-23-002381:0
Ideal exit: 16 Oct 2023 (T+270)
5,378 shares@ US$4.94660.1% of flowCommon StockSEC:0000899243-23-001855:0
Ideal exit: 9 Oct 2023 (T+270)
5,378 shares@ US$4.94660.1% of flowCommon StockSEC:0000899243-23-001854:0
Ideal exit: 9 Oct 2023 (T+270)
5,378 shares@ US$4.94660.1% of flowCommon StockSEC:0000899243-23-001857:0
Ideal exit: 9 Oct 2023 (T+270)
100,070 shares@ US$4.84181.1% of flowCommon StockSEC:0000899243-23-001694:0
Ideal exit: 7 Oct 2023 (T+270)
100,070 shares@ US$4.84181.1% of flowCommon StockSEC:0000899243-23-001695:0
Ideal exit: 7 Oct 2023 (T+270)
100,070 shares@ US$4.84181.1% of flowCommon StockSEC:0000899243-23-001697:0
Ideal exit: 7 Oct 2023 (T+270)
300 shares@ US$4.97670.0% of flowCommon StockSEC:0000899243-22-038468:0
Ideal exit: 8 Sept 2023 (T+270)
300 shares@ US$4.97670.0% of flowCommon StockSEC:0000899243-22-038466:0
Ideal exit: 8 Sept 2023 (T+270)
300 shares@ US$4.97670.0% of flowCommon StockSEC:0000899243-22-038465:0
Ideal exit: 8 Sept 2023 (T+270)
35,997 shares@ US$4.99880.4% of flowCommon StockSEC:0000899243-22-036916:0
Ideal exit: 18 Aug 2023 (T+270)
35,997 shares@ US$4.99880.4% of flowCommon StockSEC:0000899243-22-036912:0
Ideal exit: 18 Aug 2023 (T+270)
35,997 shares@ US$4.99880.4% of flowCommon StockSEC:0000899243-22-036919:0
Ideal exit: 18 Aug 2023 (T+270)
25 of 62 declarations
About COLUMN GROUP L P
COLUMN GROUP L P is a significant shareholder of Nurix Therapeutics, Inc.
